JP2022521353A5 - - Google Patents

Info

Publication number
JP2022521353A5
JP2022521353A5 JP2021559471A JP2021559471A JP2022521353A5 JP 2022521353 A5 JP2022521353 A5 JP 2022521353A5 JP 2021559471 A JP2021559471 A JP 2021559471A JP 2021559471 A JP2021559471 A JP 2021559471A JP 2022521353 A5 JP2022521353 A5 JP 2022521353A5
Authority
JP
Japan
Prior art keywords
item
peptide
amino acid
domain
items
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021559471A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022521353A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/024053 external-priority patent/WO2020198074A1/en
Publication of JP2022521353A publication Critical patent/JP2022521353A/ja
Priority to JP2022063931A priority Critical patent/JP2022082754A/ja
Publication of JP2022521353A5 publication Critical patent/JP2022521353A5/ja
Priority to JP2024123197A priority patent/JP2024149556A/ja
Pending legal-status Critical Current

Links

JP2021559471A 2019-03-22 2020-03-20 Vegfのためのd-ペプチド性化合物 Pending JP2022521353A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022063931A JP2022082754A (ja) 2019-03-22 2022-04-07 Vegfのためのd-ペプチド性化合物
JP2024123197A JP2024149556A (ja) 2019-03-22 2024-07-30 Vegfのためのd-ペプチド性化合物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962822241P 2019-03-22 2019-03-22
US62/822,241 2019-03-22
US201962865469P 2019-06-24 2019-06-24
US62/865,469 2019-06-24
PCT/US2020/024053 WO2020198074A1 (en) 2019-03-22 2020-03-20 D-peptidic compounds for vegf

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2022063931A Division JP2022082754A (ja) 2019-03-22 2022-04-07 Vegfのためのd-ペプチド性化合物
JP2024123197A Division JP2024149556A (ja) 2019-03-22 2024-07-30 Vegfのためのd-ペプチド性化合物

Publications (2)

Publication Number Publication Date
JP2022521353A JP2022521353A (ja) 2022-04-06
JP2022521353A5 true JP2022521353A5 (enExample) 2023-03-29

Family

ID=70285984

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2021559471A Pending JP2022521353A (ja) 2019-03-22 2020-03-20 Vegfのためのd-ペプチド性化合物
JP2022063931A Ceased JP2022082754A (ja) 2019-03-22 2022-04-07 Vegfのためのd-ペプチド性化合物
JP2024123197A Pending JP2024149556A (ja) 2019-03-22 2024-07-30 Vegfのためのd-ペプチド性化合物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022063931A Ceased JP2022082754A (ja) 2019-03-22 2022-04-07 Vegfのためのd-ペプチド性化合物
JP2024123197A Pending JP2024149556A (ja) 2019-03-22 2024-07-30 Vegfのためのd-ペプチド性化合物

Country Status (7)

Country Link
US (1) US20210061861A1 (enExample)
EP (1) EP3941580A1 (enExample)
JP (3) JP2022521353A (enExample)
KR (2) KR20220044612A (enExample)
CN (3) CN114989298A (enExample)
TW (3) TW202523683A (enExample)
WO (1) WO2020198074A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024524613A (ja) 2021-07-14 2024-07-05 ライシア セラピューティクス, インコーポレイテッド M6pr細胞表面受容体結合化合物及びコンジュゲート
KR102662922B1 (ko) * 2022-05-31 2024-05-03 주식회사 세네릭스 신규의 d-아미노산 유도체 및 이를 포함하는 약학 조성물
CN120835794A (zh) 2023-01-18 2025-10-24 利西亚治疗公司 M6pr结合化合物和缀合物

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE240394T1 (de) 1992-10-23 2003-05-15 Immunex Corp Methoden zur herstellung löslicher, oligomerer proteine
SE9400088D0 (sv) 1994-01-14 1994-01-14 Kabi Pharmacia Ab Bacterial receptor structures
US6740734B1 (en) 1994-01-14 2004-05-25 Biovitrum Ab Bacterial receptor structures
US6811779B2 (en) 1994-02-10 2004-11-02 Imclone Systems Incorporated Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
GB9708265D0 (en) 1997-04-24 1997-06-18 Nycomed Imaging As Contrast agents
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
US6887470B1 (en) 1999-09-10 2005-05-03 Conjuchem, Inc. Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
EP1274720A4 (en) 2000-04-12 2004-08-18 Human Genome Sciences Inc FUSION PROTEINS CONTAINING ALBUMIN
US20050054051A1 (en) 2001-04-12 2005-03-10 Human Genome Sciences, Inc. Albumin fusion proteins
EP1587944A4 (en) * 2002-03-01 2007-03-21 Dyax Corp KDR AND VEGF / KDR BINDING PEPTIDES AND THEIR USE FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
US20030191056A1 (en) 2002-04-04 2003-10-09 Kenneth Walker Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
US8545809B2 (en) 2007-01-11 2013-10-01 Immunomedics, Inc. Methods and compositions for improved 18F labeling of proteins, peptides and other molecules
EP2077272A1 (en) 2007-12-21 2009-07-08 Affibody AB Polypeptide libraries with a predetermined scaffold
WO2010014830A2 (en) * 2008-07-30 2010-02-04 Cosmix Therapeutics Llc Peptide therapeutics that bind vegf and methods of use thereof
EP2638063A4 (en) * 2010-11-12 2014-04-23 Reflexion Pharmaceuticals Inc GB1 PEPTIDE LIBRARIES AND CONNECTIONS AND SCREENING METHOD THEREFOR
WO2014071234A1 (en) * 2012-11-02 2014-05-08 The Governing Council Of The University Of Toronto Gb1 peptidic compounds and methods for making and using the same
HK1218534A1 (zh) * 2013-03-14 2017-02-24 多伦多大学管理委员会 支架化肽文库以及其制备和筛选方法
KR102497083B1 (ko) 2013-08-28 2023-02-07 애피바디 에이비 돌연변이된 스캐폴드를 갖는 결합 폴리펩티드
WO2015112700A1 (en) * 2014-01-22 2015-07-30 Wisconsin Alumni Research Foundation Alpha/beta-peptide mimics of z-domain peptides
WO2016059068A1 (en) * 2014-10-13 2016-04-21 Affibody Ab Vegfr-2 binding polypeptides
JP2016123342A (ja) * 2014-12-26 2016-07-11 国立研究開発法人産業技術総合研究所 Vegf結合性ペプチド
BR112017020986A2 (pt) * 2015-04-02 2018-08-14 Molecular Partners Ag. proteínas de ligação recombinantes e seu uso
WO2016208761A1 (ja) * 2015-06-25 2016-12-29 公立大学法人大阪府立大学 薬物複合体

Similar Documents

Publication Publication Date Title
JP7775358B2 (ja) 単一ドメイン血清アルブミン結合タンパク質
AU2021286418B2 (en) Designed ankyrin repeat domains with binding specificity for serum albumin
KR102365977B1 (ko) 단일 쇄 가변 단편 cd3 결합 단백질
KR101997241B1 (ko) 삼중특이성 결합 단백질 및 사용 방법
JP6486908B2 (ja) 肝細胞増殖因子に結合する設計アンキリン反復タンパク質
US20240084009A1 (en) Single chain variable fragment cd3 binding proteins
CN110835375B (zh) 一种抗pd-1/egfr双特异性抗体及其用途
KR20150091138A (ko) Her2에 대항하는 적어도 두 개 이상의 반복 도메인을 포함하는 결합 단백질
EP2486058A1 (en) Polypeptides for binding to the "receptor for advanced glycation endproducts" as well as compositions and methods involving the same
TWI825459B (zh) 一種SIRPα-Fc融合蛋白
JP6032735B2 (ja) Vegf結合性融合ペプチド
JP2016027801A (ja) 改良された抗血清アルブミン結合変異体
KR20180068982A (ko) 혈관신생 인자에 대한 매우 강력한 모노클로날 항체
TW201742958A (zh) 功能性抗體片段的高通量篩選方法及其免疫偶聯物以及用於篩選之適體-藥物偶聯物
TWI867218B (zh) 靶向her2的抗原結合建構體及用途
JP7119225B2 (ja) Pdgf受容体に対する抗体およびその用途
CN114025795B (zh) 使用靶向her2的双特异性抗原结合构建体治疗胆道癌的方法
KR20260005269A (ko) c-Met를 표적으로 하는 다중 특이성 항체
JP2026500703A (ja) 融合タンパク質
JP2017043625A (ja) Vegf結合性ペプチド
WO2016059068A1 (en) Vegfr-2 binding polypeptides
RU2852383C1 (ru) Бифункциональный слитый белок и его применение
KR20130097628A (ko) 아포리포단백질을 포함하는 항체-약물 결합체
JP2026515648A (ja) 抗bcam抗体及び抗体薬物複合体